showed a trendp = 0.233
Regarding other transplant outcomes, FLT3-ITD –positive patients showed a trend toward increased CIR (2-year CIR: 22.8% [95% CI, 21.8–23.9] vs. 15.2% [95% CI, 14.8–15.5], p = 0.233), as well as inferior OS (2-year OS: 70.9% [95% CI, 57.0–88.0] vs. 76.0% [95% CI, 67.3–85.8], p = 0.399); however, none of these differences reached statistical significance (Fig. 3 B and C).